In Silico Toxicology: Where are We at and Where are We Going? John C. Dearden, Liverpool John Moores University, speaking at ADME & Predictive Toxicology Europe 2012
When is a Genotoxin not a Genotoxin? Richard Walmsley, University of Manchester, speaking at ADME & Predictive Toxicology Europe
miRNA Replacement Therapy in Cancer through Polyplex-Mediated miRNA Delivery In Vivo Professor Achim Aigner, Institute of Pharmacology / bpc, Philipps-University Marburg, speaking at RNAi Europe 2011.
Biotests for Hazard Characterization of Waste Dr Reinhilde Weltens, Vito, speaking at Advances in Biosensors and Biodetection.
Drug Discovery Outsourcing: the Importance of Integration in the Selection of Higher Quality Clinical Candidates Simone Braggio, Director, Head of Drug Metabolism & Pharmacokinetics, Aptuit speaking at Pharma Outsourcing Congress 2011
Approach to Quick Lead Optimization Including Physicochemical and ADME Profiling Pranas Japertas, Director, ACD Labs, Speaking at Medchem Europe 2011.
Preclinical Drug Safety: High Quality Data obtained with a New Automated Patch Clamp Platform Olaf Scheel, CSO, Cytocentrics AG speaking at Pharma Outsourcing Congress 2011
In a Virtual World, Where Are the Walls of the House? The New Outsourcing Katya Tsaioun, President, Apredica speaking at Pharma Outsourcing Congress 2011
Voltage-Gated Sodium Channel Activators with Differing Efficacies Stimulate Neurite Outgrowth in Cerebrocortical Neurons Thomas Murray, Professor and Chair, Creighton University School of Medicine, speaking at Screening Europe 2010